Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Erica, Koch"'
Autor:
Germán Calderillo, Matías Muñoz-Medel, Edelmira Carbajal, Miguel Córdova-Delgado, Doris Durán, Ignacio N. Retamal, Piga Fernández, Absalón Espinoza, Rodrigo Salas, María de la Paz Mastretta, Héctor Galindo, Bruno Nervi, Jorge Madrid, Cesar Sánchez, Carolina Ibáñez, José Peña, Sebastián Mondaca, Francisco Acevedo, Erica Koch, Mauricio P. Pinto, Marcelo Garrido
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 647-657 (2020)
PURPOSE Like other malignancies, GI stromal tumors (GIST) are highly heterogeneous. This not only applies to histologic features and malignant potential, but also to geographic incidence rates. Several studies have reported GIST incidence and prevale
Externí odkaz:
https://doaj.org/article/54b7f631dd464e6ea2167e4500c37e96
Autor:
Jin H. Han, Erica Koch, Alvin D. Jeffery, Thomas J. Reese, Chad Dorn, Shannon Pugh, Melissa Rubenstein, Jo Ellen Wilson, Corey Campbell, Michael J. Ward
Publikováno v:
Academic Emergency Medicine. 30:262-269
Autor:
Erica Koch, Gabriel Rada
Publikováno v:
Medwave, Vol 16, Iss Suppl2 (2016)
La neutropenia febril prolongada conlleva un alto riesgo de desarrollar infecciones fúngicas invasoras, por lo que habitualmente se administra terapia antifúngica empírica en estos casos. Sin embargo, esta se asocia a importantes efectos adversos,
Externí odkaz:
https://doaj.org/article/0d40bd4c9196463e855c0e3d4039fa13
Autor:
Jorge Madrid, Héctor Galindo, César Sánchez, Erica Koch, Mauricio P. Pinto, Eugenio Vinés, Sebastian Mondaca, José Peña, Benjamin Walbaum, Bruno Nervi, M. Loreto Bravo, Jose R. Valbuena, Francisco Acevedo, Marcelo Garrido, Gonzalo Pizarro, Matías Muñoz-Medel, Roger Gejman, Sergio González, Juan Briones, Carolina Ibañez, Miguel Cordova-Delgado
Publikováno v:
Clinical Lung Cancer. 21:e250-e254
Background Checkpoint inhibitors (CPIs) such as Pembrolizumab have recently become the standard treatment for Non-Small Cell Lung Cancers (NSCLC) in patients without Epidermal Growth Factor (EGFR) gene alterations. Previous reports suggest no signifi
Autor:
Bruno Nervi, M. Loreto Bravo, Héctor Galindo, José Peña, Sebastian Mondaca, Carolina Ibañez, Marcelo Garrido, Francisco Acevedo, Benjamin Walbaum, César Sánchez, Erica Koch, Lidia Medina, Mauricio P. Pinto, Tomás Merino, Mauricio Camus, Francisco Domínguez, Jorge Madrid
Publikováno v:
Current Medical Research and Opinion. 36:1195-1199
Objective: Clinical guidelines recommend the use of endocrine therapy (ET) in advanced hormone receptor positive (HR+) human epidermal growth factor receptor type 2 negative (HER2-) breast cancer (...
Publikováno v:
Open Access Emergency Medicine. 11:179-199
Shock index (SI) is defined as the heart rate (HR) divided by systolic blood pressure (SBP). It has been studied in patients either at risk of or experiencing shock from a variety of causes: trauma, hemorrhage, myocardial infarction, pulmonary emboli
Publikováno v:
The American Journal of Emergency Medicine. 37:1428-1432
The Surviving Sepsis Campaign implemented a 3-hour bundle including blood cultures, lactate, intravenous fluids, and antibiotics to improve mortality in sepsis. Though difficult to achieve, bundle compliance is associated with decreased hospital mort
Publikováno v:
Disease-a-Month. 68:101388
Autor:
Montserrat Molgó, Erica Koch, Álvaro Abarzúa-Araya, Juan Camilo Castro, Eugenio Vinés, Augusto León, Cristian Navarrete-Dechent, Nicolás Droppelmann, Jorge Madrid, Francisco Villanueva, Pablo Uribe, Miguel Ángel Villaseca, Katherine Droppelmann, Héctor Galindo, Sebastian Mondaca, Pablo H. Montero, Michael A. Marchetti, Consuelo Cárdenas, Francisco Domínguez
Publikováno v:
Journal of the European Academy of Dermatology and Venereology
Autor:
César Sánchez, Erica Koch, Marcelo Garrido, Jorge Madrid, Patricio Salas, José Peña, Matías Muñoz-Medel, Jose R. Valbuena, felipe bannura, Carolina Ibañez, Francisco Acevedo, Miguel Cordova-Delgado, Bruno Nervi, Mauricio P. Pinto, Héctor Galindo, Sebastian Mondaca, maria eliana solovera
Publikováno v:
ecancermedicalscience
Background: Thymic epithelial tumors are rare and highly heterogeneous. Reports from the United States suggest an overall incidence of 0.15 per 100,000/year. In contrast, the incidence of these tumors in Latin America is largely unknown and reports a